The Amgen v. Sandoz BPCIA Decision Stands: the Federal Circuit Denies an En Banc Rehearing

Fitzpatrick Case Update
October 22, 2015

On October 16, 2015, the Federal Circuit declined to rehear en banc its July decision interpreting key provisions of the Biologics Price Competition and Innovation Act of 2009 (“BPCIA”).
Written by: Lawrence S. Perry and H. Rachael Million-Perez

View Attachment (PDF)